Quantcast

Latest Debiopharm Group Stories

2011-07-26 02:00:00

LAUSANNE, Switzerland and RALEIGH, North Carolina, July 26, 2011 /PRNewswire/ -- INC Research, LLC, a therapeutically focused contract research organisation (CRO) with a trusted process for delivering reliable results, and Debiopharm Group(TM) ("Debiopharm"), a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics, today announced a strategic partnership.

2011-07-14 03:45:00

LAUSANNE, Switzerland, July 14, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative therapies, primarily in oncology, has appointed a number of management figures to key positions, which will help ensure the perennial success of the group over the long term. Although Debiopharm is a private company, it is committed to ensure the same level of financial rigor and...

2011-05-04 02:00:00

LAUSANNE, Switzerland and NEW HAVEN, Connecticut, May 4, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Yale University (Yale), a premier university with a long tradition of both basic and clinically directed biomedical research, announce an exclusive worldwide license agreement concerning the development and commercialization of Debio 1036, a first-in-class...


Word of the Day
  • an ornament or knob in the shape of a flower
  • In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.
[ "The word 'fleuron' comes from French."]